INDIVIDUAL REACTIONS FROM THE PERIPHERAL NERVOUS SYSTEM IN THE CONDITIONS OF THE COVID-19 PANDEMIC

DOI: https://doi.org/10.29296/25877305-2022-03-05
Download full text PDF
Issue: 
3
Year: 
2022

A. Raevskaya; A. Deryabin; Associate Professor I. Vyshlova, MD; Professor S. Karpov, MD
Stavropol State Medical University

During the ongoing pandemic, more and more neurologists are seeing patients who have had a new coronavirus infection. The authors are of the opinion that vaccination is the only right way to reduce the incidence and, as a result, mortality from COVID-19. This article provides information on clinical cases of possible complications from the peripheral nervous system after a new coronavirus infection COVID-19.
Keywords: 
neurology
COVID-19
new coronavirus infection
vaccination
Bell’s palsy
facial nerve neuritis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210. DOI: 10.33029/0206-4952-2021-42-3-198-210
  2. Fotuhi M., Ali M., Somayeh M. et al. Neurobiology of COVID-19. J Alzheimers Dis. 2020; 76 (1): 3–19. DOI: 10.3233/JAD-200581
  3. Shirshova E.V., Knaub V.V., Baklaushev V.P. Klinicheskij sluchaj sindroma Gijena–Barre, indutsirovannogo COVID-19. Klinicheskaja praktika. 2021; 12 (2): 110–8. DOI: 10.17816/clinpract72264
  4. Dzhanibekova M.B., Zvjagintseva E.M., Vyshlova I.A. i dr. Nevrologicheskie rasstrojstva, assotsiirovannye s COVID-19. Vestnik molodogo uchenogo. 2021; 10 (2): 87–94.
  5. Fedin A.I. Nevrologicheskaja klinicheskaja patologija, assotsiirovannaja s COVID-19. Nevrologija i nejrohirurgija. Vostochnaja Evropa. 2020; 10 (2): 312–29. DOI: 10.34883/PI.2020.2.2.024
  6. Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 54–8. DOI: 10.1016/j.ijid.2020.03.062
  7. Fernandez C.E., Franz C.K., Ko J.H. et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021; 298 (3): 117–30. DOI: 10.1148/radiol.202020-3116
  8. Andalib S., Biller J., Di Napoli M. et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021; 21 (3): 9. DOI: 10.10-07/s11910-021-01102-5
  9. Belopasov V.V., Zhuravleva E.N., Nugmanova N.P. i dr. Postkovidnye nevrologicheskie sindromy. Klinicheskaja praktika. 2021; 12 (2): 69–82. DOI: 10.17816/clinpract71137
  10. Statistika vaktsinatsii ot koronavirusa v Rossii. URL: https://coronavirus-control.ru/statistika-vakczinaczii/
  11. Pojasnitel'naja zapiska po vaktsine ot COVID-19. Moderna, vaktsina ot COVID-19 (mRNK-1273). Vsemirnaja organizatsija zdravoohranenija. URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21100_russian_moderna-vaccine-explainer.pdf?sfvrsn=750f0e1f_5
  12. Pojasnitel'naja zapiska po vaktsine ot COVID-19. ChAdOx1-S [rekombinantnaja] vaktsina ot COVID-19. Vsemirnaja organizatsija zdravoohranenija. URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21102_russian_astrazeneca_vaccine-explainer13b2736d-2427-4c9e-bd3c-0e8d8e1511dc.pdf?sfvrsn=ec951194_5
  13. Ber M., Frotsher M. Topicheskij diagnoz v nevrologii po Peteru Duusu: anatomija, fiziologija, klinika. Per. s angl. pod red. O.S. Levina. 3-e izd. M.: Prakticheskaja meditsina, 2018; s. 205–6.
  14. Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med. 2004; 350 (9): 896–903. DOI: 10.1056/NEJMoa030595
  15. Iftikhar H. et al. Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine. Cureus. 2021; 13 (6): e15935. DOI: 10.7759/cureus.15935
  16. Ozonoff A., Nanishi E., Levy O. Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021; 21 (4): 450–2. DOI: 10.1016/S1473-3099(21)00076-1
  17. Burrows A. et al. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ case reports. 2021; 14 (7): e243829. DOI: 10.1136/bcr-2021-243829
  18. FDA. FDA Briefing document Pfizer-BioNTech Covid-19 Vaccine [Internet], 2020. URL: https://www.fda.gov/media/144245/download
  19. COVID-19 mRNA Pfizer-BioNTech vaccine analysis print [Internet]. Assets.publishing.service.gov.uk, 2021. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977005/COVID-19_mRNA_Pfizer-_BioNTech_Vaccine_Analysis_Print.pdf
  20. Kratkoe rukovodstvo. Vaktsinatsija protiv COVID-19 vaktsinoj CoronaVac kompanii Sinovac (Sinovac-CoronaVac). Vsemirnaja organizatsija zdravoohranenija. Evropejskoe regional'noe bjuro. URL: https://www.euro.who.int/__data/assets/pdf_file/0008/508760/Sinovac-quick-guide-COVID-19-rus.pdf
  21. Wan E.Y.F. et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet. Infect Dis. 2022; 22 (1): 64–72. DOI: 10.1016/S1473-3099(21)00451-5
  22. Shemer A., Pras E., Einan-Lifshitz A. et al. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2021; 147 (8): 739–43. DOI: 10.1001/jamaoto.2021.1259
  23. Volk G.F., Kuttenreich A.M., Geitner M. et al. Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2]. Laryngorhinootologie. 2021; 100 (7): 526–8. DOI: 10.1055/a-1501-0470
  24. Repajic M. et al. Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. 2021; 13: 100217. DOI: 10.1016/j.bbih.2021.100217
  25. Jung J., Park D.C., Jung S.Y. et al. Bilateral facial palsy. Acta Otolaryngol. 2019; 39 (10): 934–8. DOI: 10.1080/00016489.2019.1651134
  26. Mason M.C. et al. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence? Cureus. 2021; 13 (8): e17602. DOI: 10.7759/cureus.17602
  27. Dem'janovskaja E.G., Kryzhanovskij S.M., Vasil'ev A.S. i dr. Nevrologicheskie aspekty COVID-19. Taktika vedenija patsientov nevrologom s uchetom epidemiologicheskoj situatsii. Lechaschij Vrach. 2021; 2: 54–60. DOI: 10.26295/OS.2021.63.96.011
  28. Fasano A., Cavallieri F., Canali E. et al. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020; 41: 1651–3. DOI: 10.1007/s10072-020-04460-z
  29. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
  30. Kang L., Li Y., Hu S. et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020; 7 (3): e14. DOI: 10.1016/S 2215–0366(20)30047-X
  31. Zubair A.S., McAlpine L.S., Gardin T. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020; 77 (8): 1018–27. DOI: 10.1001/jamaneurol.2020.2065
  32. Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.) DOI: 10.33029/0206-4952-2021-42-3-198-210
  33. Fotuhi M., Ali M., Somayeh M. et al. Neurobiology of COVID-19. J Alzheimers Dis. 2020; 76 (1): 3–19. DOI: 10.3233/JAD-200581
  34. Shirshova E.V., Knaub V.V., Baklaushev V.P. A Clinical Case of Guillain–Barré Syndrome Associated with COVID-19. Journal of Clinical Practice. 2021; 12 (2): 110–8 (in Russ.). DOI: 10.17816/clinpract72264
  35. Dzhanibekova M.B., Zvyagintseva E.M., Vyshlova I.A. et al. Neurological disorders, associated with COVID-19. Vestnik molodogo uchenogo. 2021; 10 (2): 87–94 (in Russ.).
  36. Fedin A. Neurological clinical manifestations, associated with COVID-19. Nevrologiya i neirokhirurgiya. Vostochnaya Evropa. 2020; 10 (2): 312–29 (in Russ.). DOI: 10.34883/PI.2020.2.2.024
  37. Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 54–8. DOI: 10.1016/j.ijid.2020.03.062
  38. Fernandez C.E., Franz C.K., Ko J.H. et al. Imaging review of peripheral nerve injuries in patients with COVID-19. Radiology. 2021; 298 (3): 117–30. DOI: 10.1148/radiol.202020-3116
  39. Andalib S., Biller J., Di Napoli M. et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021; 21 (3): 9. DOI: 10.10-07/s11910-021-01102-5
  40. Belopasov V.V., Zhuravleva E.N., Nugmanova N.P. et al. Post-COVID-19 Neurological Syndromes. Journal of Clinical Practice. 2021; 12 (2): 69–82 (in Russ.). DOI: 10.17816/clinpract71137
  41. Statistika vaktsinatsii ot koronavirusa v Rossii (in Russ.). URL: https://coronavirus-control.ru/statistika-vakczinaczii/
  42. Poyasnitel’naya zapiska po vaktsine ot COVID-19. Moderna, vaktsina ot COVID-19 (mRNK-1273). WHO (in Russ.). URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21100_russian_moderna-vaccine-explainer.pdf?sfvrsn=750f0e1f_5
  43. Poyasnitel’naya zapiska po vaktsine ot COVID-19. ChAdOx1-S [rekombinantnaya] vaktsina ot COVID-19. WHO (in Russ.). [URL: https://www.who.int/docs/default-source/coronaviruse/act-accelerator/covax/21102_russian_astrazeneca_vaccine-explainer13b2736d-2427-4c9e-bd3c-0e8d8e1511dc.pdf?sfvrsn=ec951194_5
  44. Ber M., Frotsher M. Topicheskii diagnoz v nevrologii po Peteru Duusu: anatomiya, fiziologiya, klinika. Per. s angl. pod red. O.S. Levina. 3-e izd. M.: Prakticheskaya meditsina, 2018; s. 205–6 (in Russ.).
  45. Mutsch M., Zhou W., Rhodes P. et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med. 2004; 350 (9): 896–903. DOI: 10.1056/NEJMoa030595
  46. Iftikhar H. et al. Bell’s Palsy After 24 Hours of mRNA-1273 SARS-CoV-2 Vaccine. Cureus. 2021; 13 (6): e15935. DOI: 10.7759/cureus.15935
  47. Ozonoff A., Nanishi E., Levy O. Bell’s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021; 21 (4): 450–2. DOI: 10.1016/S1473-3099(21)00076-1
  48. Burrows A. et al. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ case reports. 2021; 14 (7): e243829. DOI: 10.1136/bcr-2021-243829
  49. FDA. FDA Briefing document Pfizer-BioNTech Covid-19 Vaccine [Internet], 2020. URL: https://www.fda.gov/media/144245/download
  50. COVID-19 mRNA Pfizer-BioNTech vaccine analysis print [Internet]. Assets.publishing.service.gov.uk, 2021. URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/977005/COVID-19_mRNA_Pfizer-_BioNTech_Vaccine_Analysis_Print.pdf
  51. Kratkoe rukovodstvo. Vaktsinatsiya protiv COVID-19 vaktsinoi CoronaVac kompanii Sinovac (Sinovac-CoronaVac). WHO (in Russ.). URL: https://www.euro.who.int/__data/assets/pdf_file/0008/508760/Sinovac-quick-guide-COVID-19-rus.pdf
  52. Wan E.Y.F. et al. Bell’s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. Lancet. Infect Dis. 2022; 22 (1): 64–72. DOI: 10.1016/S1473-3099(21)00451-5
  53. Shemer A., Pras E., Einan-Lifshitz A. et al. Association of COVID-19 Vaccination and Facial Nerve Palsy: A Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2021; 147 (8): 739–43. DOI: 10.1001/jamaoto.2021.1259
  54. Volk G.F., Kuttenreich A.M., Geitner M. et al. Eine akute Fazialisparese als mögliche Impfkomplikation bei einer Impfung gegen SARS-CoV-2 [Acute facial paresis as a possible complication of vaccination against SARS-CoV-2]. Laryngorhinootologie. 2021; 100 (7): 526–8. DOI: 10.1055/a-1501-0470
  55. Repajic M. et al. Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy. Brain Behav Immun Health. 2021; 13: 100217. DOI: 10.1016/j.bbih.2021.100217
  56. Jung J., Park D.C., Jung S.Y. et al. Bilateral facial palsy. Acta Otolaryngol. 2019; 39 (10): 934–8. DOI: 10.1080/00016489.2019.1651134
  57. Mason M.C. et al. Bilateral Facial Nerve Palsy and COVID-19 Vaccination: Causation or Coincidence? Cureus. 2021; 13 (8): e17602. DOI: 10.7759/cureus.17602
  58. Demianovskaia E.G., Kryzhanovskiy S.M., Vasiliev A.S. et al. Neurological aspects of COVID-19. Management of patients with neurological diseases considering epidemiological situation. Lechaschi Vrach. 2021; 2: 54–60 (in Russ.). DOI: 10.26295/OS.2021.63.96.011
  59. Fasano A., Cavallieri F., Canali E. et al. First motor seizure as presenting symptom of SARS-CoV-2 infection. Neurol Sci. 2020; 41: 1651–3. DOI: 10.1007/s10072-020-04460-z
  60. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
  61. Kang L., Li Y., Hu S. et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020; 7 (3): e14. DOI: 10.1016/S 2215–0366(20)30047-X
  62. Zubair A.S., McAlpine L.S., Gardin T. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020; 77 (8): 1018–27. DOI: 10.1001/jamaneurol.2020.2065